Charles Drew University
Los Angeles, California, 90059, United States
NCT Number: NCT00876928
Vitamin D supplementation in minority subjects with both pre-diabetes and low vitamin D levels will delay the development of diabetes.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Interventional
Not applicable
Los Angeles, California, 90059, United States
Low vitamin D levels 1) are associated with abnormalities in insulin secretion and insulin action, 2) predict the development of diabetes in those without diabetes, and 3) are more common in people with diabetes. Minority populations (African-Americans and Latinos) are more likely to have both low levels of vitamin D and diabetes. This study will identify minority individuals who are at increased risk for diabetes (those with central obesity, family history of diabetes in first degree relatives and either with hypertension or being treated for hypertension), and determine if they have both pre-diabetes, ie, impaired fasting glucose and/or impaired glucose tolerance, and low levels of vitamin D. Those that have both will be randomized to either high doses of vitamin D or placebo and insulin secretion and action as well as changes in the oral glucose tolerance test (reversion to normal, maintenance of pre-diabetes or development of diabetes) will be monitored at 3 month intervals for one year. This study will test the hypothesis that the increased amount of diabetes in minority populations may be due in part to low levels of vitamin D and whether supplementing this vitamin may delay the development of diabetes.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
liquid vitamin D3 dissolved in medium chain triglyceride once a week
medium chain triglyceride given once per week
Time frame: one year
Diabetes defined by a FPG>=126 mg/dl or a 2-hr glucose concentration on an OGTT of >=200 mg/dl
Time frame: Baseline, 3, 6, 9, 12 months
Measure of insulin secretion multiplied by measure of insulin sensitivity,both derived from oral glucose tolerance test; higher values are better
Charles Drew University of Medicine and Science
Other
Effect of Vitamin D Supplementation on Pre-Diabetes in a Minority Population
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01286922
Behavior, Diabetes Mellitus
Baton Rouge, Louisiana, United States
View Trial DetailsNCT00233298
Body Weight, Diabetes
Baltimore, Maryland, United States
View Trial DetailsNCT02129595
Diabetes Mellitus, Diabetes Mellitus, Type 2
Maastricht, Limburg, Netherlands
View Trial DetailsNCT05563090
Cardiovascular Diseases, Diabete Mellitus
Singapore
View Trial Details